-
Vedolizumab for the treatment of inflammatory bowel diseases
Reena Khanna & Brian G Feagan
Drug Evaluation: Clinical Investigation
-
Vedolizumab for the treatment of inflammatory bowel diseases
Reena Khanna & Brian G Feagan
Drug Evaluation: Clinical Investigation
-
Vedolizumab for the treatment of inflammatory bowel diseases
Reena Khanna & Brian G Feagan
Drug Evaluation: Clinical Investigation
-
Vedolizumab for the treatment of inflammatory bowel diseases
Reena Khanna & Brian G Feagan
Drug Evaluation: Clinical Investigation
-
Vedolizumab for the treatment of inflammatory bowel diseases
Reena Khanna & Brian G Feagan
Drug Evaluation: Clinical Investigation
-
Vedolizumab for the treatment of inflammatory bowel diseases
Reena Khanna & Brian G Feagan
Drug Evaluation: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
Allopurinol-thiopurine combination therapy in inflammatory bowel disease
Margien L Seinen, Nanne KH de Boer, Adriaan A van Bodegraven, Stephen B Hanauer & Frank Hoentjen
Special Report: Clinical Investigation
-
Allopurinol-thiopurine combination therapy in inflammatory bowel disease
Margien L Seinen, Nanne KH de Boer, Adriaan A van Bodegraven, Stephen B Hanauer & Frank Hoentjen
Special Report: Clinical Investigation
-
Allopurinol-thiopurine combination therapy in inflammatory bowel disease
Margien L Seinen, Nanne KH de Boer, Adriaan A van Bodegraven, Stephen B Hanauer & Frank Hoentjen
Special Report: Clinical Investigation
-
Allopurinol-thiopurine combination therapy in inflammatory bowel disease
Margien L Seinen, Nanne KH de Boer, Adriaan A van Bodegraven, Stephen B Hanauer & Frank Hoentjen
Special Report: Clinical Investigation
-
Allopurinol-thiopurine combination therapy in inflammatory bowel disease
Margien L Seinen, Nanne KH de Boer, Adriaan A van Bodegraven, Stephen B Hanauer & Frank Hoentjen
Special Report: Clinical Investigation
-
Allopurinol-thiopurine combination therapy in inflammatory bowel disease
Margien L Seinen, Nanne KH de Boer, Adriaan A van Bodegraven, Stephen B Hanauer & Frank Hoentjen
Special Report: Clinical Investigation
-
Therapeutic area variability in the collection of data supporting protocol end points and objectives
Kenneth Getz & Stella Stergiopoulos
Clinical Trail Methodology: Clinical Investigation
-
Therapeutic area variability in the collection of data supporting protocol end points and objectives
Kenneth Getz & Stella Stergiopoulos
Clinical Trail Methodology: Clinical Investigation
-
Therapeutic area variability in the collection of data supporting protocol end points and objectives
Kenneth Getz & Stella Stergiopoulos
Clinical Trail Methodology: Clinical Investigation
-
Therapeutic area variability in the collection of data supporting protocol end points and objectives
Kenneth Getz & Stella Stergiopoulos
Clinical Trail Methodology: Clinical Investigation
-
Therapeutic area variability in the collection of data supporting protocol end points and objectives
Kenneth Getz & Stella Stergiopoulos
Clinical Trail Methodology: Clinical Investigation
-
Therapeutic area variability in the collection of data supporting protocol end points and objectives
Kenneth Getz & Stella Stergiopoulos
Clinical Trail Methodology: Clinical Investigation
-
New developments in the diagnosis and treatment of axial spondyloarthritis
Pedro Machado, Robert Landewe, Desiree van der Heijde
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of axial spondyloarthritis
Pedro Machado, Robert Landewe, Desiree van der Heijde
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of axial spondyloarthritis
Pedro Machado, Robert Landewe, Desiree van der Heijde
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of axial spondyloarthritis
Pedro Machado, Robert Landewe, Desiree van der Heijde
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of axial spondyloarthritis
Pedro Machado, Robert Landewe, Desiree van der Heijde
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of axial spondyloarthritis
Pedro Machado, Robert Landewe, Desiree van der Heijde
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term follow-up of human papillomavirus vaccine efficacy
Matti Lehtinen
Editorial: Clinical Investigation
-
Long-term follow-up of human papillomavirus vaccine efficacy
Matti Lehtinen
Editorial: Clinical Investigation
-
Long-term follow-up of human papillomavirus vaccine efficacy
Matti Lehtinen
Editorial: Clinical Investigation
-
Long-term follow-up of human papillomavirus vaccine efficacy
Matti Lehtinen
Editorial: Clinical Investigation
-
Long-term follow-up of human papillomavirus vaccine efficacy
Matti Lehtinen
Editorial: Clinical Investigation
-
Long-term follow-up of human papillomavirus vaccine efficacy
Matti Lehtinen
Editorial: Clinical Investigation
-
Corrigendum: Clin Invest (2012); 2(9) 603-614.
Corrigendum: Clinical Investigation
-
Corrigendum: Clin Invest (2012); 2(9) 603-614.
Corrigendum: Clinical Investigation
-
Corrigendum: Clin Invest (2012); 2(9) 603-614.
Corrigendum: Clinical Investigation
-
Corrigendum: Clin Invest (2012); 2(9) 603-614.
Corrigendum: Clinical Investigation
-
Corrigendum: Clin Invest (2012); 2(9) 603-614.
Corrigendum: Clinical Investigation
-
Corrigendum: Clin Invest (2012); 2(9) 603-614.
Corrigendum: Clinical Investigation
-
New developments in the treatment of ALK-driven malignancies
Luca Mologni & Carlo Gambacorti-Passerini
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of ALK-driven malignancies
Luca Mologni & Carlo Gambacorti-Passerini
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of ALK-driven malignancies
Luca Mologni & Carlo Gambacorti-Passerini
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of ALK-driven malignancies
Luca Mologni & Carlo Gambacorti-Passerini
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of ALK-driven malignancies
Luca Mologni & Carlo Gambacorti-Passerini
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of ALK-driven malignancies
Luca Mologni & Carlo Gambacorti-Passerini
Review: Clinical Trail Outcomes: Clinical Investigation
-
Immunotherapy & cancer - making the past prologue Immunotherapeutic combinations for cancer
Susan F Slovin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Immunotherapy & cancer - making the past prologue Immunotherapeutic combinations for cancer
Susan F Slovin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Immunotherapy & cancer - making the past prologue Immunotherapeutic combinations for cancer
Susan F Slovin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Immunotherapy & cancer - making the past prologue Immunotherapeutic combinations for cancer
Susan F Slovin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Immunotherapy & cancer - making the past prologue Immunotherapeutic combinations for cancer
Susan F Slovin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Immunotherapy & cancer - making the past prologue Immunotherapeutic combinations for cancer
Susan F Slovin
Review: Clinical Trail Outcomes: Clinical Investigation